References
- Arber DA, Orazi A, Hassserijan RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. doi:10.1182/blood.2022015850
- Sutheralnd DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34 positive cells in peripheral blood and cord blood by flow cytometry. Exp Hematol. 1994;22(10):1003–1010.
- Eidenschink L, DiZerega G, Rodgers K, Bartlett M, Wells DA, Loken MR. Basal levels of CD34 positive cells in peripheral blood differ between individuals and are stable for 18 months. Cytometry B Clin Cytom. 2012;82(1):18–25. doi:10.1002/cyto.b.20611
- Bender JG, Unverzagt KL, Walker DE, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77(12):2591–2596. doi:10.1182/blood.V77.12.2591.2591
- Kikuchi-Taura A, Soma T, Matsuyama T, Stern DM, Taguci A. A new protocol for quantifying CD34+ cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J. 2006;33(4):427–429.
- Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991;77(2):400–409. doi:10.1182/blood.V77.2.400.400
- Kutok JL, Roma AO, Lemire SJ, Dorfman DM. Four-color flow cytometric immunophenotypic determination of peripheral blood CD4+ T-lymphocyte counts: a comparison of validity and cost-effectiveness with a two-color method. Am J Clin Pathol. 1998;110(4):465–470. doi:10.1093/ajcp/110.4.465
- Gratama JW, Orfao A, Barmett D, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry. 1998;34(3):128–142. doi:10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO;2-D
- Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Jee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5(3):213–226. doi:10.1089/scd.1.1996.5.213
- Gajkowska A, Oldak T, Jastrzewska M, et al. Flow cytometric enumeration of CD34+ positive hematopoietic and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods. Folia Histochem Cytobiol. 2006;44(1):53–60.
- Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy. 2009;11(5):595–605. doi:10.1080/14653240902923161
- Kroft SH, Karandikar NJ. Flow cytometric analysis of acute leukemias, myelodysplastic syndromes, and myeloproliferative disorders. In: Carey JL, McCoy JP, Keren DF, editors. Flow Cytometry in Clinical Diagnosis. 4th ed. Chicago, IL: American Society for Clinical Pathology; 2007:168–214.
- Harrington AM, Olteanu H, Kroft SH. A dissection of the CD45/side scatter “blast gate”. Am J Clin Pathol. 2012;137(5):800–804. doi:10.1309/AJCPN4G1IZPABRLH
- Sun T, Sangaline R, Ryder J, et al. Gating strategy for immunophenotyping of leukemia and lymphoma. Am J Clin Pathol. 1997;108(2):152–157. doi:10.1093/ajcp/108.2.152
- Passamonti F, Vanelli L, Malabarba L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica. 2003;88(10):1123–1129.